MYRIAD GENETICS - Dusseldorf Stock Exchang
MYRIAD GENETICS - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
Market Cap & Net Worth: MYRIAD GENETICS - Dusseldorf Stock Exchang (MYD)
MYRIAD GENETICS - Dusseldorf Stock Exchang (DU:MYD) has a market capitalization of $42.63K (€41.53K) as of March 18, 2026. Listed on the DU stock exchange, this Germany-based company holds position #42540 globally and #6659 in its home market, demonstrating a -6.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MYRIAD GENETICS - Dusseldorf Stock Exchang's stock price €4.30 by its total outstanding shares 9658 (9.66K).
MYRIAD GENETICS - Dusseldorf Stock Exchang Market Cap History: 2015 to 2026
MYRIAD GENETICS - Dusseldorf Stock Exchang's market capitalization history from 2015 to 2026. Data shows change from $398.53K to $42.63K (-18.12% CAGR).
MYRIAD GENETICS - Dusseldorf Stock Exchang Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MYRIAD GENETICS - Dusseldorf Stock Exchang's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
MYRIAD GENETICS - Dusseldorf Stock Exchang's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $157.68K | $753.80 Million | $125.30 Million | 0.00x | 0.00x |
| 2017 | $285.71K | $771.40 Million | $21.80 Million | 0.00x | 0.01x |
| 2018 | $245.96K | $772.60 Million | $131.10 Million | 0.00x | 0.00x |
| 2019 | $235.95K | $851.10 Million | $4.60 Million | 0.00x | 0.05x |
| 2020 | $145.83K | $638.60 Million | -$199.50 Million | 0.00x | N/A |
| 2022 | $134.38K | $690.60 Million | -$27.20 Million | 0.00x | N/A |
| 2023 | $174.48K | $678.40 Million | -$112.00 Million | 0.00x | N/A |
| 2024 | $123.92K | $753.20 Million | -$263.30 Million | 0.00x | N/A |
Competitor Companies of MYD by Market Capitalization
Companies near MYRIAD GENETICS - Dusseldorf Stock Exchang in the global market cap rankings as of March 18, 2026.
Key companies related to MYRIAD GENETICS - Dusseldorf Stock Exchang by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
MYRIAD GENETICS - Dusseldorf Stock Exchang Historical Marketcap From 2015 to 2026
Between 2015 and today, MYRIAD GENETICS - Dusseldorf Stock Exchang's market cap moved from $398.53K to $ 42.63K, with a yearly change of -18.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €42.63K | -18.10% |
| 2025 | €52.05K | -58.00% |
| 2024 | €123.92K | -28.98% |
| 2023 | €174.48K | +29.84% |
| 2022 | €134.38K | -44.15% |
| 2021 | €240.60K | +64.99% |
| 2020 | €145.83K | -38.19% |
| 2019 | €235.95K | -4.07% |
| 2018 | €245.96K | -13.91% |
| 2017 | €285.71K | +81.20% |
| 2016 | €157.68K | -60.44% |
| 2015 | €398.53K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MYRIAD GENETICS - Dusseldorf Stock Exchang was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $42.63K USD |
| MoneyControl | $42.63K USD |
| MarketWatch | $42.63K USD |
| marketcap.company | $42.63K USD |
| Reuters | $42.63K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.